A detailed history of Lokken Investment Group LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Lokken Investment Group LLC holds 2,300 shares of NVO stock, worth $234,002. This represents 0.12% of its overall portfolio holdings.

Number of Shares
2,300
Previous 2,293 0.31%
Holding current value
$234,002
Previous $327,000 16.51%
% of portfolio
0.12%
Previous 0.16%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$119.07 - $145.42 $833 - $1,017
7 Added 0.31%
2,300 $273,000
Q2 2024

Aug 09, 2024

BUY
$122.71 - $146.91 $281,374 - $336,864
2,293 New
2,293 $327,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $230B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Lokken Investment Group LLC Portfolio

Follow Lokken Investment Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lokken Investment Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lokken Investment Group LLC with notifications on news.